First Trust AlphaDEX Fund II Files Definitive Proxy for Shareholder Vote

First Trust Exchange-Traded Alphadex Fund II DEF 14A Filing Summary
Field	Detail
Company	First Trust Exchange-Traded Alphadex Fund II
Form Type	DEF 14A
Filed Date	Jul 11, 2025
Risk Level	low
Sentiment	neutral

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Shareholder Meeting, First Trust, AlphaDEX Fund, ETF, Corporate Governance

TL;DR

**First Trust AlphaDEX Fund II is calling a shareholder meeting for an 'important matter' – pay attention, it could signal changes to your ETF holdings!**

AI Summary

The DEF 14A filing by FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND II, filed on July 11, 2025, is a definitive proxy statement for a special meeting of shareholders. This filing indicates that no filing fee was required, suggesting a routine corporate governance matter rather than a significant transaction requiring a fee calculation. The Trust, located at 120 East Liberty Drive, Suite 400, Wheaton, Illinois 60187, is seeking shareholder approval for an unspecified 'important matter' as detailed in the proxy materials. The filing lists numerous sub-funds, including First Trust Emerging Markets AlphaDEX Fund (FEM), First Trust Europe AlphaDEX Fund (FEP), and First Trust Brazil AlphaDEX Fund (FBZ), among others, indicating a broad portfolio of AlphaDEX-strategy ETFs. The document itself does not disclose specific revenue or net income figures, nor does it detail key business changes or strategic outlook, focusing solely on the procedural aspects of a shareholder meeting. Risks are not explicitly quantified or detailed within this initial DEF 14A, which primarily serves as a notice for an upcoming vote.

Why It Matters

This DEF 14A signals an upcoming shareholder vote for First Trust Exchange-Traded AlphaDEX Fund II, which could impact the strategic direction or operational structure of its diverse AlphaDEX ETF offerings. For investors, understanding the 'important matter' to be voted on is crucial as it could affect fund management, fees, or investment objectives, potentially altering their portfolio's risk-reward profile. Employees and customers of First Trust could see implications depending on the nature of the proposed changes, while the broader market will watch for any shifts in the competitive landscape of smart-beta ETFs, especially given First Trust's significant presence with funds like FEM, FEP, and FDT.

Risk Assessment

Risk Level: low — The risk level is low because this DEF 14A is a procedural filing for a shareholder meeting, not an announcement of a major financial event or crisis. It explicitly states 'No fee required,' which typically applies to routine corporate governance matters, not high-risk transactions. The filing itself does not contain any specific financial or operational risks, only the notice of an upcoming vote.

Analyst Insight

Investors should immediately seek out the full proxy materials to understand the 'important matter' being voted on by First Trust Exchange-Traded AlphaDEX Fund II shareholders. Evaluate how the proposed changes could impact your investment strategy and consider participating in the vote if you hold shares.

Key Numbers

0001445546-25-004727 — Accession Number (Unique identifier for the SEC filing)
20250711 — Filed As Of Date (Date the document was officially filed)
6 — Public Document Count (Number of public documents associated with this filing)
811-22519 — SEC File Number (Registration number for the Trust)
251118910 — Film Number (Internal SEC processing number)

Key Players & Entities

FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND II (company) — Registrant filing the DEF 14A
Securities and Exchange Commission (regulator) — Recipient of the DEF 14A filing
July 11, 2025 (date) — Filing date of the DEF 14A
July 8, 2025 (date) — Date of the Dear Shareholders letter
120 East Liberty Drive, Suite 400, Wheaton, Illinois 60187 (location) — Business address of the Trust
630-765-8000 (phone_number) — Business phone of the Trust
First Trust Emerging Markets AlphaDEX Fund (company) — Sub-fund listed in the filing
First Trust Europe AlphaDEX Fund (company) — Sub-fund listed in the filing
First Trust Brazil AlphaDEX Fund (company) — Sub-fund listed in the filing
First Trust Developed Markets ex-US AlphaDEX Fund (company) — Sub-fund listed in the filing

FAQ

What is the purpose of the DEF 14A filing by First Trust Exchange-Traded AlphaDEX Fund II?

The DEF 14A filing by First Trust Exchange-Traded AlphaDEX Fund II is a definitive proxy statement, indicating that the Trust is calling a special meeting of shareholders to address an 'important matter' as of July 8, 2025.

When was the DEF 14A filed by First Trust Exchange-Traded AlphaDEX Fund II?

The DEF 14A for First Trust Exchange-Traded AlphaDEX Fund II was filed with the Securities and Exchange Commission on July 11, 2025, with a conformed period of report of July 8, 2025.

What is the business address of First Trust Exchange-Traded AlphaDEX Fund II?

The business address for First Trust Exchange-Traded AlphaDEX Fund II is 120 East Liberty Drive, Suite 400, Wheaton, Illinois 60187, with a business phone number of 630-765-8000.

Does the First Trust Exchange-Traded AlphaDEX Fund II filing require a fee?

No, the DEF 14A filing by First Trust Exchange-Traded AlphaDEX Fund II explicitly states 'No fee required,' indicating it's likely a routine corporate governance matter.

What types of funds are mentioned in the First Trust Exchange-Traded AlphaDEX Fund II filing?

The filing lists various AlphaDEX funds, including First Trust Emerging Markets AlphaDEX Fund (FEM), First Trust Europe AlphaDEX Fund (FEP), First Trust Brazil AlphaDEX Fund (FBZ), and First Trust Developed Markets ex-US AlphaDEX Fund (FDT), among others.

What should investors do regarding the First Trust Exchange-Traded AlphaDEX Fund II DEF 14A?

Investors should review the full proxy materials to understand the specific 'important matter' being presented for a vote at the special shareholder meeting and consider its potential impact on their investments.

What is the Central Index Key (CIK) for First Trust Exchange-Traded AlphaDEX Fund II?

The Central Index Key (CIK) for First Trust Exchange-Traded AlphaDEX Fund II is 0001510337, which is used by the SEC to identify the entity.

Are there any specific risks detailed in this First Trust Exchange-Traded AlphaDEX Fund II filing?

This specific DEF 14A filing for First Trust Exchange-Traded AlphaDEX Fund II does not detail any specific financial or operational risks; it primarily serves as a procedural notice for an upcoming shareholder meeting.

What is the significance of the 'Dear Shareholders' letter in the First Trust Exchange-Traded AlphaDEX Fund II filing?

The 'Dear Shareholders' letter, dated July 8, 2025, serves as the formal notification to shareholders about the upcoming special meeting and the 'important matter' that will be discussed and voted upon.

How many public documents are associated with this First Trust Exchange-Traded AlphaDEX Fund II filing?

There are 6 public documents associated with this DEF 14A filing for First Trust Exchange-Traded AlphaDEX Fund II, as indicated by the 'PUBLIC DOCUMENT COUNT' field.

Industry Context

The First Trust Exchange-Traded AlphaDEX Fund II operates within the exchange-traded fund (ETF) industry, specifically focusing on actively managed or quantitatively driven strategies. This segment of the ETF market competes on unique index methodologies and performance. The industry is characterized by increasing inflows into passive and quantitative strategies, driven by demand for lower costs and specific factor exposures.

Regulatory Implications

As a registered investment company, the Trust is subject to the oversight of the SEC and various securities laws. The DEF 14A filing itself is a regulatory requirement to ensure transparent communication with shareholders regarding voting matters. Failure to comply with proxy solicitation rules could lead to regulatory scrutiny.

What Investors Should Do

Review the proxy materials carefully.
Determine voting eligibility and method.
Attend the special meeting or vote by proxy.

Key Dates

2025-07-11: Filing of Definitive Proxy Statement (DEF 14A) — This date marks the official filing of the proxy statement, informing shareholders about the upcoming special meeting and the matters to be voted upon.
2025-07-08: Letter to Shareholders — This is the date of the letter accompanying the proxy statement, indicating the formal communication to shareholders regarding the special meeting.

Glossary

DEF 14A: A Definitive Proxy Statement filed with the SEC, used to solicit shareholder votes on important corporate matters. (This is the primary document type for this filing, detailing the purpose of the shareholder meeting and the proposals for vote.)
AlphaDEX: A proprietary methodology used by First Trust to construct indexes that aim to select stocks based on specific quantitative factors. (This term is central to the fund's name and strategy, indicating the underlying investment approach of the various sub-funds.)
Registrant: The entity that is required to file reports with the SEC, in this case, First Trust Exchange-Traded AlphaDEX Fund II. (Identifies the fund itself as the entity making the filing and seeking shareholder approval.)
Schedule 14A: The SEC schedule form used for definitive proxy statements. (Specifies the regulatory form under which this filing is made.)

Year-Over-Year Comparison

This filing is a DEF 14A for a special meeting, not an annual report. Therefore, direct year-over-year financial comparisons of revenue, net income, or margins are not applicable. The focus is on governance and shareholder voting, not on reporting operational or financial performance changes from a prior period.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on July 11, 2025 regarding FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND II.

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR